Jason Northcutt joined Bass, Berry & Sims’ Washington, D.C. office in February 2016. He has more than 16 years experience advising a wide variety of corporate and business clients and firms doing business with the federal government. In addition, Jason represents both private equity firms and companies in corporate transactions, having advised on matters totaling more than $2 billion in the last 10 years alone. He assists both publicly and privately held companies in structuring and managing complex transactions, as well as advises entrepreneurs on raising capital and in the development of creative and effective financing techniques.
Jason works with leaders in the government contracting, aerospace and defense, manufacturing, healthcare, life sciences, retail, information technology and business services industries.
His practice includes:
Prior to joining Bass, Berry & Sims, Jason was a partner at Sheppard, Mullin, Richter & Hampton LLP.
American Health Law Association (AHLA)
Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners
Represented Serco Inc. in its definitive Asset Purchase Agreement to acquire Alion Science & Technology Corporation’s Naval Systems Business Unit, including its Canadian business and a small number of related contract operations, for $225 million. The acquisition, subject to regulatory approvals, is expected to close in the second half of 2019. Serco Inc., a provider of professional, technology, and management services, will strengthen its presence in naval support with this acquisition, and will become a stronger integrated maritime solutions provider for the U.S Navy and other customers.
Represented BluSky Restoration in its sale to Dominus Capital.
Alpha-Omega Change Engineering Sold to CAE USA
Represented Serco Inc. in its acquisition of BTP Systems, LLC
Represented IMA Consulting in its sale to New Mountain Capital
Represented IBB Consulting in its definitive agreement to be acquired by Accenture
Represented Envision Healthcare (NYSE: EVHC) in its definitive agreement to sell American Medical Response (AMR) to KKR’s portfolio company, Air Medical Group Holdings (AMGH) for $2.4 billion
Represented Enlighten IT Consulting in its acquisition by MacAulay-Brown, Inc.
Represented Engility in its sale of IRG (International Resources Group Ltd.) to RTI (Research Triangle Institute)